Session » Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II
-
Abstract Number: 1676
Improving Sensitivity to Change of the Modified Rodnan Skin Score over Time
-
Abstract Number: 1677
Low Baseline Impedance in Proximal Esophagus and Decreased Pspw Index May Related with Pathogenesis of Interstitial Lung Disease in Systemic Sclerosis
-
Abstract Number: 1678
Pathogenic Mechanisms of Esophageal Peristaltic Dysfunction By High Resolution Manometry in Patients with Systemic Sclerosis
-
Abstract Number: 1679
Different Cut-Offs for Renal Resistive Index Reflect Renal and Other Organ Involvement and Predict Worsening in SSc Patients
-
Abstract Number: 1680
Higher Baseline Monocyte Count Is Associated with More Extensive Skin Involvement and Higher Mortality in Systemic Sclerosis
-
Abstract Number: 1682
Significance of Anti-Topoisomerase I Antibodies in Routine Clinical Testing
-
Abstract Number: 1683
Smoking Behaviour and the Progression of Organ Manifestations in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
-
Abstract Number: 1684
Effectiveness and Safety of Tacrolimus Following Intravenous Cyclophosphamide Pulse Therapy As the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease
-
Abstract Number: 1685
Factors Associated with the 6-Minute Walk Distance in Patients with Systemic Sclerosis
-
Abstract Number: 1686
Topical Nitroglycerine (NTG) Vs Matching Vehicle in Secondary Raynaud Phenomenon (RP) – a Double-Blind Crossover Study of Subjective and Physiologic Responses to Controlled Cold Challenge
-
Abstract Number: 1687
Efficacy of Rituximab for Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Study of 28 Patients
-
Abstract Number: 1688
Stem Cell-Enriched Lipotransfer Substantially Improves Measures of Appearance and Function Due to Facial Fibrosis in Systemic Sclerosis
-
Abstract Number: 1689
Using Electronic Health Record Algorithms to Accurately Identify Patients with Systemic Sclerosis
-
Abstract Number: 1690
Nailfold Capillary Counts Are Associated with Clinical Manifestations in Connective Tissue Disease Japanese Patitents
-
Abstract Number: 1691
Risk of Development of Definite Disease in Patients with Early Systemic Sclerosis
-
Abstract Number: 1692
Decreased Lean Body Mass, Body Fat and Bone Mineral Density in Scleroderma Patients Are Associated with Disease Activity and Physical Activity
-
Abstract Number: 1693
To What Extend Do Auto-Antibodies Help to Identify High-Risk Patients in Systemic Sclerosis?
-
Abstract Number: 1694
Efficacy of an Intensive 24-Week Physiotherapy Programme in Scleroderma Patients – Preliminary Data from a Single-Center Controlled Study
-
Abstract Number: 1695
Baseline Characteristics and Outcomes in a Retrospective Cohort of Patients with Systemic Sclerosis Related Interstitial Lung Disease
-
Abstract Number: 1696
Performance of Forced Vital Capacity and Lung Diffusion Cut-Points for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis
-
Abstract Number: 1697
Unique Characteristics of Scleroderma Among African Americans: A Population Based Study
-
Abstract Number: 1698
Quantitative Analyze of Peripheral Vascular Bed in Patients with Systemic Sclerosis By Using Photoacoustic Imaging Technology: A Pilot Study
-
Abstract Number: 1699
A 10-Year National Trend in Acute Coronary Syndrome Among Hospitalized Patients with Systemic Sclerosis
-
Abstract Number: 1700
Focusing on Pulmonary Vascular Disease at Early Stage of Systemic Sclerosis: Exercise-Induced Pulmonary Arterial Hypertension and Gene Co-Expression Networks Involved in Its Pathogenesis
-
Abstract Number: 1701
Can Durometer Differentiate Limited Versus Diffuse Cutaneous Systemic Sclerosis?